Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 24, 2016
Patent Application Number
14535070
Date Filed
November 6, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
This invention pertains to methods of treating systemic lupus erythematosus and Sjogren's Syndrome with compounds that selectively inhibit the activity of Bcl-2 anti-apoptotic proteins. Specifically, the current invention is directed to treatment with compounds that selectively inhibit the activity of Bcl-2 proteins, with a lesser affinity for inhibiting the activity of other BCL-2 family proteins, including Bcl-xL.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
